Jacqueline Rodriguez
Women's Health · Huntington Park, CANPI 1598831505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 45.0% of the total. Among women's health clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Boehringer Ingelheim$233
- Amgen$226
- AstraZeneca$144
- Astellas Pharma US Inc$135
- Xeris Pharmaceuticals, Inc.$116
- plus $520 from 13 others
What the payments were for
- Food & beverage$2,43297%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $1,124 |
| Boehringer Ingelheim | 9 | $233 |
| Amgen | 17 | $226 |
| AstraZeneca | 3 | $144 |
| Astellas Pharma US Inc | 4 | $135 |
| Xeris Pharmaceuticals, Inc. | 5 | $116 |
| Amarin Pharma, Inc. | 4 | $86 |
| Exact Sciences | 4 | $78 |
| Johnson & Johnson | 3 | $54 |
| Lilly USA, LLC | 2 | $48 |
| Shield Therapeutics Inc | 2 | $47 |
| Bayer | 2 | $41 |
| Genentech USA, Inc. | 1 | $32 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| Optinose US, Inc. | 1 | $27 |
| Abbott | 1 | $24 |
| Merck | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,498 in reported general payments places this provider in the 90th percentile of 480 women's health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 46 | $44,364 |
| OzempicSemaglutide | 41 | $38,337 |
| TradjentaLinagliptin | 30 | $24,539 |
| RybelsusSemaglutide | 15 | $18,242 |
| JanuviaSitagliptin Phosphate | 23 | $18,239 |
| FarxigaDapagliflozin Propanediol | 23 | $15,744 |
| EliquisApixaban | 12 | $7,801 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $7,592 |
| Atorvastatin Calcium | 413 | $4,839 |
| Fenofibrate | 146 | $4,314 |
| Febuxostat | 20 | $3,797 |
| Celecoxib | 32 | $3,468 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $2,085 |
| Glipizide ErGlipizide | 89 | $2,050 |
| Levothyroxine Sodium | 128 | $2,022 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $233 | $68,90376 claims |
| Novo NordiskOzempic, Rybelsus | $1,124 | $56,57956 claims |
| MerckJanuvia | $21 | $18,23923 claims |
| AstraZenecaFarxiga | $144 | $15,74423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 women's health providers in California.
Other women's health in Huntington Park
- Barbara DehnMountain View$87K
- Zaruhi HarutyunyanWest Hollywood$55K
- Roberta MoradfarWest Hollywood$30K
- Patricia GeraghtyWalnut Creek$26K
- Katherine KetzStockton$26K
- Debbie BarishBerkeley$16K
- Raisa HowardEl Segundo$11K
- Mary FesselWoodland$8K
- Kay MorelandSanta Maria$6K
- Allison AlixOrange$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.